Publisher Correction: Molecular analysis of primary melanoma T cells identifies patients at risk for metastatic recurrence

Nat Cancer. 2020 Apr;1(4):470. doi: 10.1038/s43018-020-0049-z.

Wiebke Pruessmann^#^{1

2}, Julie Rytlewski^#³, James Wilmott^#⁴, Martin C Mihm Jr¹, Grace H Attrill⁴, Beatrice Dyring-Andersen^{1

5}, Paul Fields³, Qian Zhan¹, Andrew J Colebatch^{4

6}, Peter M Ferguson^{4

6}, John F Thompson^{4

7}, Klaus Kallenbach⁸, Erik Yusko³, Rachael A Clark¹, Harlan Robins^{3

9}, Richard A Scolyer^#^{4

6}, Thomas S Kupper^#¹⁰

¹ Department of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA.
² Department of Dermatology, University of Luebeck, Luebeck, Germany.
³ Adaptive Biotechnologies, Seattle, WA, USA.
⁴ Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia.
⁵ Novo Nordisk Foundation Centre for Protein Research, University of Copenhagen, Copenhagen, Denmark.
⁶ Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
⁷ Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.
⁸ Department of Surgical Pathology, Zealand University Hospital, Roskilde, Denmark.
⁹ Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
¹⁰ Department of Dermatology and Harvard Medical School, Brigham and Women's Hospital, Boston, MA, USA. tkupper@bwh.harvard.edu.

^# Contributed equally.

No abstract available

Publication types